138 related articles for article (PubMed ID: 7130613)
1. An advance in ophthalmic pharmacology. The use of the epinephrine pro-drug dipivalyl epinephrine in the treatment of glaucoma.
Garzia R
J Am Optom Assoc; 1982 Sep; 53(9):727-30. PubMed ID: 7130613
[TBL] [Abstract][Full Text] [Related]
2. [Clinical studies conducted with a new epinephrine derivative for the treatment of glaucoma (Dipivalyl epinephrine)].
Bischoff P
Klin Monbl Augenheilkd; 1978 Apr; 172(4):565-8. PubMed ID: 349251
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of 0.1% dipivalyl epinephrine and 1% epinephrine in patients with glaucoma or ocular hypertension].
Shao H; Sun XY; Bai FG
Zhonghua Yan Ke Za Zhi; 1994 Mar; 30(2):104-7. PubMed ID: 8001439
[TBL] [Abstract][Full Text] [Related]
4. Experience with dipivalyl epinephrine. Its effectiveness, alone or in combination, and its side effects.
Cebon L; West RH; Gillies WE
Aust J Ophthalmol; 1983 Aug; 11(3):159-61. PubMed ID: 6639507
[TBL] [Abstract][Full Text] [Related]
5. Dipivefrin: current concepts.
Goldberg I; Kolker AE; Kass MA; Becker B
Aust J Ophthalmol; 1980 May; 8(2):147-50. PubMed ID: 7004425
[TBL] [Abstract][Full Text] [Related]
6. [The pressure reducing effects of pilocarpin in combination with Dipivalyl-epinephrine in glaucoma simplex (author's transl)].
Krieglstein GK; Leydhecker W
Klin Monbl Augenheilkd; 1979 Jul; 175(1):86-90. PubMed ID: 491472
[TBL] [Abstract][Full Text] [Related]
7. Drop attack in glaucoma. The Melbourne experience with topical miotics, adrenergic and neuronal blocking drops.
West RH; Cebon L; Gillies WE
Aust J Ophthalmol; 1983 Aug; 11(3):149-53. PubMed ID: 6639505
[TBL] [Abstract][Full Text] [Related]
8. [Guanethidine/dipivefrin and pilocarpine in the treatment of increased intraocular pressure].
Ober M; Scharrer A; Dausch D
Klin Monbl Augenheilkd; 1987 Feb; 190(2):103-4. PubMed ID: 3573660
[TBL] [Abstract][Full Text] [Related]
9. [Experiences with the effectiveness and tolerance of guanethidine/dipivefrin-AT in the treatment of increased intraocular pressure].
Ober M; Scharrer A
Klin Monbl Augenheilkd; 1986 Jan; 188(1):64-6. PubMed ID: 3959479
[TBL] [Abstract][Full Text] [Related]
10. Serial administration of adrenergic antagonist and agonist ("pulsatile therapy") reduces the incidence of long-term drift to timolol in humans.
Gandolfi SA; Vecchi M
Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):684-8. PubMed ID: 8595970
[TBL] [Abstract][Full Text] [Related]
11. [Use of 0.1% dipivefrine chloride for treatment of patients with open angle glaucoma].
Czechowicz-Janicka K; Kamińska E; Staszkiewicz J
Klin Oczna; 1995; 97(7-8):248-51. PubMed ID: 8531459
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic index of epinephrine and dipivefrin with nasolacrimal occlusion.
Zimmerman TJ; Sharir M; Nardin GF; Fuqua M
Am J Ophthalmol; 1992 Jul; 114(1):8-13. PubMed ID: 1621789
[TBL] [Abstract][Full Text] [Related]
13. Effects of topical 1-epinephrine and dipivalyl epinephrine on intraocular pressure and pupil size in the normotensive and glaucomatous Beagle.
Gwin RM; Gelatt KN; Gum GG; Peiffer RL
Am J Vet Res; 1978 Jan; 39(1):83-6. PubMed ID: 629453
[TBL] [Abstract][Full Text] [Related]
14. [Therapy of primary open-angle glaucoma by oftan-dipivefrin].
Egorov EA; Alekseev VN; Erichev VP; Usachev VV; Simonova SV; Iakubova LV
Vestn Oftalmol; 2000; 116(1):32-3. PubMed ID: 10741262
[TBL] [Abstract][Full Text] [Related]
15. [The additive effect of dipivefrin in patients with wide angle glaucoma treated with long-term beta-blocker therapy in comparison with clonidine].
Alimgil ML; Erda S; Benian O
Klin Monbl Augenheilkd; 1994 Aug; 205(2):114-6. PubMed ID: 7967405
[No Abstract] [Full Text] [Related]
16. [Dipivefrin: its mechanism of action, clinical efficacy and good tolerance].
Harper DG; Novack GD; Borrmann LR; Branin MJ
Ophtalmologie; 1989; 3(4):306-7. PubMed ID: 2641142
[TBL] [Abstract][Full Text] [Related]
17. A single-blind randomised trial comparing adrenaline 1.0% with dipivalyl epinephrine (propine) 0.1% in the treatment of open-angle glaucoma and ocular hypertension.
Mills KB; Jacobs NA
Br J Ophthalmol; 1988 Jun; 72(6):465-8. PubMed ID: 3291940
[TBL] [Abstract][Full Text] [Related]
18. Ocular absorption and metabolism of topically applied epinephrine and a dipivalyl ester of epinephrine.
Wei CP; Anderson JA; Leopold I
Invest Ophthalmol Vis Sci; 1978 Apr; 17(4):315-21. PubMed ID: 640779
[TBL] [Abstract][Full Text] [Related]
19. Nasolacrimal occlusion improves the therapeutic index of antiglaucoma medications.
Sharir M; Zimmerman TJ
J Assoc Acad Minor Phys; 1994; 5(2):62-7. PubMed ID: 8032178
[TBL] [Abstract][Full Text] [Related]
20. [New perspectives in glaucoma therapy with epinephrine and epinephrine derivatives (author's transl)].
Adamek R
Klin Monbl Augenheilkd; 1980 Jun; 176(6):978-81. PubMed ID: 7453024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
